Navigation Links
Fingertip Formulary Mobile(R) Now Offers Access to Real-Time Formulary Data on the iPhone
Date:6/10/2009

GLEN ROCK, N.J., June 10 /PRNewswire/ -- Fingertip Formulary(R), the leading provider of access to and insight into U.S. formulary data, introduces a free, customized mobile solution, specifically designed for the iPhone. Physicians and others may now access Fingertip Formulary's simple-to-use formulary lookup application on web pages specially designed for the iPhone. By having formulary data available at the moment prescribing decisions are made, physicians can better optimize their patients' prescription drug benefit plans.

Fingertip Formulary Mobile provides real-time access to the most comprehensive and up-to-date integrated database of managed care formulary data. Information available at the point-of-care includes the coverage (tier) level and managed care restrictions, such as prior authorizations, step therapies, and quantity limits, as well as other relevant information, for virtually all U.S. based managed care plans. Users who choose to register on the Fingertip Formulary website may create and store a customized list of plan formularies which streamlines the formulary look-up process. All formulary data pulls directly, in real-time, and always reflects the most current status available in the core database.

In addition to the formulary data, clinical drug information is available for most pharmaceutical products. Useful links to the source formularies and product websites are also included as an additional resource.

About Fingertip Formulary(R)

Fingertip Formulary (www.FingertipFormulary.com), the leading provider of access to and insight into formulary data in the United States offers comprehensive formulary data covering commercial, Medicaid, Medicare, and PBM plans, among others. The company offers a variety of unique data and marketing solutions for the pharmaceutical industry, consultants and healthcare providers that provide access to and insight into formulary data. Fingertip Formulary is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Elizabeth Marshall
    Decision Resources, Inc.
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Fingertip Formulary
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ER Wait Times at Your Fingertips
2. SMS Technology Places Eye Health Educational Information at Hispanics Fingertips
3. Nonin Medicals GO2(TM) Personal Fingertip Pulse Oximeter Empowers Patients Worldwide
4. Fingertip Formulary Analytics(R) Offers One-Click Access to Customized Formulary Data and Co-Pay Reports
5. Health Information at Your Fingertips with the Dr Foster Website Launch
6. Nonin(R) Medical Pioneers First Interoperable, Wireless Fingertip Pulse Oximeter
7. Advancing Interoperability - Nonin(R) Medical Unveils Worlds First Bluetooth(R)-Enabled, Wireless Fingertip Pulse Oximeter
8. Encision Moves Power and Safety to Surgeons Fingertips
9. What gives us fingertip dexterity?
10. Fingertip Formulary Restrictions(TM) Provides Unprecedented Access to Real- Time Managed Care Restrictions Data
11. Fingertip Formulary Mobile(TM) is Now Available for Physicians and Other Healthcare Providers Free on PDAs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and athletic trainers ... say researchers presenting their work at the American Orthopaedic Society for Sports ... evaluating the patterns of change in concussion symptom presentation, diagnostic tools used and ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid ... cancer that progresses rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens ... reoccurrence and relapse. With such a challenging diagnosis that requires immediate action, ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
(Date:7/20/2017)... ... 2017 , ... Doctors on Liens, the leading network of medical providers working ... by Dr. Russell Horine, DC to their exclusive list of medical professionals. Horine Chiropractic ... serving as the clinic director and his son Dr. Lee Horine and daughter-in-law Dr. ...
(Date:7/20/2017)... ... July 20, 2017 , ... Using CDRH’s Medical Device Quality ... 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/mdqualitydata          , Device makers have ... known as the “CY2016 Annual FDA Medical Device Quality System Data” report. CDRH ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)...  Centurion Medical Products, a leader in medical product innovation and ... removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part of a ... pain while preventing unneeded emergency department admission due to severe fecal ...
(Date:7/11/2017)... Zymo Research Corp., also known as ,The Epigenetics Company, announced today the ... precise manner using the myDNAge ™ test. Based on Horvath,s Clock, ... genetics and biostatistics at the David Geffen School of Medicine at ... proprietary DNAge ™ technology is used to analyze DNA methylation patterns ... ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... development of oral drug delivery systems, announced today that ... to schedule an End-of-Phase II meeting with Oramed for ... insulin capsule ORMD-0801 in the treatment of type 2 ... endpoints by indicating a statistically significant lowering of glucose ...
Breaking Medicine Technology: